The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.

Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Walgreens Boots Alliance's prospective sale to a private equity firm is " mostly dead ," sources told CNBC's David Faber, according to a Jan. 27 report from The Wall Street Journal. Here are five ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on ...

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Walgreens Boots (WBA) falls 6.6% as potential takeover by Sycamore Partners unlikely to happen due to DOJ lawsuit over opioid prescriptions.

Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...

This is apparently happening to Walgreens Boots Alliance (NASDAQ: WBA), according to a media report. CNBC's David Faber reported live and on-air that unnamed sources told him that a looming ...

Sycamore Partners portfolio company Rona is ... No financial terms were disclosed. PFM is a private equity investment firm in Saskatchewan with over $930 million in assets under management across ...